openPR Logo
Press release

Telmisartan Market Keyword Market Breaking down into Type and Key Companies Medtronic, General Electric Company, C. R. Bard., ConvaTec Group. Smith Medical

04-04-2019 01:19 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Telmisartan

Telmisartan

Availability of better treatment options for hypertension has lead substantial portion of the hypertensive population with controlled blood pressure. But rising population with cardiovascular, and associated disorders urges need for different antihypertensive drugs in the global market. Telmisartan is a non-peptide angiotensin receptor blocker intended for treatment of hypertension and other cardiovascular disorders. Telmisartan was approved by the US Food and Drug Administration (USFDA) in 1998, for the treatment of hypertension alone or in combination with other compounds.

The global telmisartan market size was valued at US$ 3,880.9 million in 2017, and is expected to witness a CAGR of 1.4% over the forecast period (2018 – 2026).The Texas Council on cardiovascular disease and stroke works with key players to implement plan for reducing rate of cardiovascular disease and stroke burden in Texas. The plan provides an overview of the current state of cardiovascular disease and stroke in Texas, summary of findings from the heart disease and stroke prevention system assessment, as well as information on mortality, morbidity, prevalence, and related risk factors.

Request A Sample Copy Of This Report:
www.coherentmarketinsights.com/insight/request-sample/2524

Rising prevalence of hypertension globally is creating disease burden and propelling demand for developing antihypertensive drugs in the global market. For instance, the National Health and Nutrition Examination Surveys (NHANES) provided important epidemiologic information on the prevalence and control of hypertension in the U.S., between 1960 and 2014, which stated that 26 percent of the world's adult population (972 million) was suffering from hypertension in 2000, while number increased by 31 percent (1.39 billion) in 2010, and the number is estimated to reach 1.56 billion by 2025.

Furthermore, increasing marketing approvals for generic versions of telmisartan is expected to propel growth of telmisartan market. For instance, in August 2017, Zydus Cadila received approval from the US FDA to market telmisartan and hydrochlorothiazide tablets, in the strengths of 40mg/ 12.5 mg, 80 mg/12.5 mg and 80mg/25 mg. However, drug shortages are likely to inhibit the growth of the Telmisartan market. For instance in June 2018, US FDA reported shortage of Boehringer Ingelheim Pharmaceuticals, Inc.’s, telmisartan and amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister, due to discontinuation of its business. Moreover, Drug Shortages Canada also reported shortage of Teva- Telmisartan 80mg tablet in Canada, due to lack of complying with good manufacturing practices.

Telmisartan Market- Regional Analysis

Regional segmentation of the global Telmisartan market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America hold the major share in global telmisartan market due to product launches in U.S. For instance, in July 2014, Mylan Inc., a global pharmaceutical company launched telmisartan tablets USP, 20 mg, 40 mg ,and 80 mg, which are the generic version of Boehringer Ingelheim’s Micardis tablets that received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA).

Asia Pacific is expected to witness fastest growth in the global Telmisartan market due to increasing awareness among population regarding hypertension and related cardiovascular disorders. For instance, since 2005, World Hypertension Day is celebrated in Australia in the Month of May to support stakeholders such as Hypertension Societies, patient interest groups, and pharmaceutical industries.

Download the PDF brochure:
www.coherentmarketinsights.com/insight/request-pdf/2524

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Telmisartan Market Keyword Market Breaking down into Type and Key Companies Medtronic, General Electric Company, C. R. Bard., ConvaTec Group. Smith Medical here

News-ID: 1688122 • Views: 236

More Releases from Coherent Market Insights

CAR T Cell Therapy Market Analysis By Top Players Sorrento Therapeutics Inc., Mu …
In the recent past, cancer therapy such as targeted immunotherapies that includes CAR-T cell therapies is been preferred over surgery, chemotherapy, and radiation. These target cancer cells and strengthen the patient’s immune system against the tumor. CAR-T cell therapy is a type of treatment in which T-cells derived from patient’s blood are modified in laboratory with the addition of a special protein receptor on the T-cells that attack cancer cells.
Online Gambling and Betting Market Worldwide Top Players Revenue Analysis of 888 …
Online Gambling and Betting Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2018-2026). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. Download PDF Copy @ https://www.coherentmarketinsights.com/insight/request-pdf/2511 This all-inclusive Online Gambling and Betting Market research report includes a detailed
Agriculture Robots Market Size with Top-Vendor Deere & Company,Trimble, Inc.,Agc …
Agriculture Robots Market Research report contains a qualified and in-depth examination of industry which provides overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost Profit Analysis, Gross and Gross Margin. It also covers detailed competitive outlook including the Agriculture Robots market share and company profiles of the key participants operating in the global market. Request Free sample copy here @ https://www.coherentmarketinsights.com/insight/request-pdf/1183 The report organizes
Algorithmic Trading Market will touch a new level in upcoming year
This report provides in-depth analysis of algorithmic trading market size (US$ Million), and Compound Annual Growth Rate (CAGR %) for the forecast period (2018– 2026), considering 2017 as the base year Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2476 Algorithmic trading, also termed as algo trading, is a method that uses computer programs and software to execute various trades with minimal human intervention. It has gained significant traction in the financial

All 5 Releases


More Releases for Telmisartan

Telmisartan Market Prophesied to Grow at a Faster Pace by 2026
Availability of better treatment options for hypertension has lead substantial portion of the hypertensive population with controlled blood pressure. But rising population with cardiovascular, and associated disorders urges need for different antihypertensive drugs in the global market. Telmisartan is a non-peptide angiotensin receptor blocker intended for treatment of hypertension and other cardiovascular disorders. Telmisartan was approved by the US Food and Drug Administration (USFDA) in 1998, for the treatment of
Telmisartan Market Analysis by Type, Stage, End-User Appraised By Top Players C. …
Availability of better treatment options for hypertension has lead substantial portion of the hypertensive population with controlled blood pressure. But rising population with cardiovascular, and associated disorders urges need for different antihypertensive drugs in the global market. Telmisartan is a non-peptide angiotensin receptor blocker intended for treatment of hypertension and other cardiovascular disorders. Telmisartan was approved by the US Food and Drug Administration (USFDA) in 1998, for the treatment of
Telmisartan Sales Market 2017: Rising Demand For Coming Years
Qyresearchreports include new market research report “Global Telmisartan Sales Market Report 2017” to its huge collection of research reports. This report on the global Telmisartan market has been developed by a selected group of professional market research analysts, with a solitary goal to present the current scenario of the market for Telmisartan and throw light on its growth prospects. The report targets audiences such as manufacturers of Telmisartan, government agencies, and
Global Telmisartan Market – Industry Analysis and Future Forecast by 2021 with …
Qyresearchreports include new market research report “Global Telmisartan Market 2016 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast to 2021″ to its huge collection of research reports. The global Telmisartan is the core objective of examination in this research report recently added to our extensive database. The report to a great degree is a spellbinding and savvy archive that helps chalk out a careful and comprehensive investigative Telmisartan, covering
Global Telmisartan Market 2016 Industry, Analysis, Research, Share, Growth, Sale …
The Global Telmisartan Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Telmisartan industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Telmisartan market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status. Secondly, development policies and plans are discussed as well as manufacturing
Global Telmisartan (144701-48-4) Market 2016 - Teva Pharmaceutical, Divis Labora …
Telmisartan belongs to a class of medications known as angiotensin II receptor antagonists. These medications reduce blood pressure by blocking the actions of a chemical (angiotensin II) that causes blood vessels to constrict or tighten. It is used to treat mild to moderate high blood pressure. Telmisartan is also used to reduce the risk of death after a heart attack in people who cannot use another type of medication called